This website is intended for healthcare professionals only and contains promotional content.

Report an adverse event here
Link Logo
United Kingdom - English

United Kingdom - English

United Kingdom | English

These country specific websites are specifically intended for healthcare professionals in listed countries only.

Europe

Deutschland - DeutschDeutschland - Deutsch España - EspañolEspaña - Español Italia - ItalianoItalia - Italiano United Kingdom - EnglishUnited Kingdom - English

NOTICE: Kyowa Kirin International has agreed a joint venture with Grünenthal GmbH for the Established Medicines portfolio. The new company, KKI NewCo (known as Grünenthal Meds), is responsible for the content on this page. For more information please click here.​

Welcome to the Grünenthal Meds Healthcare Professional Information Hub.

This site contains medical education, medical resources and information on disease signs and symptoms intended for UK Healthcare Professionals only. Login or register to access additional content such as upcoming events and webinars.

Therapy Areas

About Us

Grünenthal Meds was established in August 2023, as part of a Joint Venture Collaboration between Grünenthal GmbH and Kyowa Kirin. Headquartered in the UK, we are responsible for managing a portfolio of 13 medicines across six key therapeutic areas, including cancer pain, constipation, and bone health. Through a network of affiliates and key partners, we are bringing these important products to patients in need around the globe. For more information on the Joint Venture Collaboration, please contact infoUK@grunenthalmeds.com

Average: